Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120689805 | 12068980 | 5 | F | 20151023 | 20160816 | 20160211 | 20160826 | EXP | JP-AMGEN-JPNCT2016016287 | AMGEN | 62.00 | YR | A | F | Y | 37.10000 | KG | 20160826 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120689805 | 12068980 | 1 | PS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 6 MG/KG, Q2WK | 6 | MG/KG | Y | 125147 | 6 | MG/KG | SOLUTION FOR INJECTION | QOW | |||
| 120689805 | 12068980 | 2 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 6 MG/KG, Q2WK | 6 | MG/KG | Y | 125147 | 6 | MG/KG | SOLUTION FOR INJECTION | QOW | |||
| 120689805 | 12068980 | 3 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 6 MG/KG, Q2WK | 6 | MG/KG | Y | 125147 | 6 | MG/KG | SOLUTION FOR INJECTION | QOW | |||
| 120689805 | 12068980 | 4 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous bolus | 400 MG/M2, Q2WEEKS | 14000 | MG/M2 | U | 0 | 400 | MG/M**2 | QOW | ||||
| 120689805 | 12068980 | 5 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous drip | 2400 MG/M2, Q2WEEKS | 14000 | MG/M2 | U | 0 | 2400 | MG/M**2 | QOW | ||||
| 120689805 | 12068980 | 6 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous bolus | 400 MG/M2, Q2WEEKS | 14000 | MG/M2 | U | 0 | 400 | MG/M**2 | QOW | ||||
| 120689805 | 12068980 | 7 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous drip | 2400 MG/M2, Q2WEEKS | 14000 | MG/M2 | U | 0 | 2400 | MG/M**2 | QOW | ||||
| 120689805 | 12068980 | 8 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous bolus | 400 MG/M2, Q2WEEKS | 14000 | MG/M2 | U | 0 | 400 | MG/M**2 | QOW | ||||
| 120689805 | 12068980 | 9 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous drip | 2400 MG/M2, Q2WEEKS | 14000 | MG/M2 | U | 0 | 2400 | MG/M**2 | QOW | ||||
| 120689805 | 12068980 | 10 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 85 MG/M2, Q2WEEKS | 425 | MG/M2 | U | 0 | 85 | MG/M**2 | QOW | ||||
| 120689805 | 12068980 | 11 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 85 MG/M2, Q2WEEKS | 425 | MG/M2 | U | 0 | 85 | MG/M**2 | QOW | ||||
| 120689805 | 12068980 | 12 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 85 MG/M2, Q2WEEKS | 425 | MG/M2 | U | 0 | 85 | MG/M**2 | QOW | ||||
| 120689805 | 12068980 | 13 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | 200 MG/M2, Q2WEEKS | 1000 | MG/M2 | U | 0 | 200 | MG/M**2 | QOW | ||||
| 120689805 | 12068980 | 14 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | 200 MG/M2, Q2WEEKS | 1000 | MG/M2 | U | 0 | 200 | MG/M**2 | QOW | ||||
| 120689805 | 12068980 | 15 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | 200 MG/M2, Q2WEEKS | 1000 | MG/M2 | U | 0 | 200 | MG/M**2 | QOW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120689805 | 12068980 | 1 | Colon cancer |
| 120689805 | 12068980 | 4 | Colon cancer |
| 120689805 | 12068980 | 10 | Colon cancer |
| 120689805 | 12068980 | 13 | Colon cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120689805 | 12068980 | OT |
| 120689805 | 12068980 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120689805 | 12068980 | Conjunctivitis | |
| 120689805 | 12068980 | Constipation | |
| 120689805 | 12068980 | Drug eruption | |
| 120689805 | 12068980 | Febrile neutropenia | |
| 120689805 | 12068980 | Malaise | |
| 120689805 | 12068980 | Nausea | |
| 120689805 | 12068980 | Neuropathy peripheral | |
| 120689805 | 12068980 | Sepsis | |
| 120689805 | 12068980 | Stomatitis | |
| 120689805 | 12068980 | Tumour associated fever |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120689805 | 12068980 | 1 | 20151016 | 20151016 | 0 | |
| 120689805 | 12068980 | 2 | 20151112 | 20151127 | 0 | |
| 120689805 | 12068980 | 3 | 20151228 | 20160122 | 0 | |
| 120689805 | 12068980 | 4 | 20151016 | 20151016 | 0 | |
| 120689805 | 12068980 | 5 | 20151016 | 20151016 | 0 | |
| 120689805 | 12068980 | 6 | 20151112 | 20151127 | 0 | |
| 120689805 | 12068980 | 7 | 20151112 | 20151127 | 0 | |
| 120689805 | 12068980 | 8 | 20151228 | 20160122 | 0 | |
| 120689805 | 12068980 | 9 | 20151228 | 20160122 | 0 | |
| 120689805 | 12068980 | 10 | 20151016 | 20151016 | 0 | |
| 120689805 | 12068980 | 11 | 20151112 | 20151127 | 0 | |
| 120689805 | 12068980 | 12 | 20151228 | 20160122 | 0 | |
| 120689805 | 12068980 | 13 | 20151016 | 20151016 | 0 | |
| 120689805 | 12068980 | 14 | 20151112 | 20151127 | 0 | |
| 120689805 | 12068980 | 15 | 20151228 | 20160122 | 0 |